credentis
CURODONTTM is developed, manufactuered and distributed by credentis.
credentis combines state-of-the-art chemistry, oral biology, experience in the development of medical devices and a network of scientists and opinion leaders in dentistry.
The peptide that is present in CURODONT™ has been patented by the University of Leeds and was licensed by credentis for the worldwide development and application in dentistry.
credentis is an incorporation according to Swiss law with its headquarters at the TECHNOPARK® Aargau in Windisch.